Physician profile
Gary L Greenlee
NPI 1043497043
$916.40
in general payments reported to CMS, 2019-2025
11 companies · $145 in 2025
The $145 reported for 2025 was more than what 82% of Chiropractor providers received nationally (typical 2025 total: $40.91).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $52.18 · 2020: $33.81 · 2021: $103 · 2022: $23.30 · 2023: $122 · 2024: $437 · 2025: $145.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $704.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $704.27 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $298.91 | 2024-2025 | Caplyta |
| Abbvie INC. | $212.64 | 2022-2025 | |
| Harmony Biosciences LLC | $90.35 | 2024 | |
| Avanir Pharmaceuticals, INC. | $71.49 | 2019-2020 | |
| Philips North America LLC | $64.66 | 2023-2024 | (8874) Incourage |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $57.58 | 2020-2021 | |
| Novo Nordisk INC | $44.43 | 2021 | |
| Paratek Pharmaceuticals, INC. | $29.83 | 2023-2024 | Nuzyra |
| Nevro Corp. | $17.60 | 2024 | Senza |
| Apria Healthcare LLC | $15.33 | 2021 | |
| Exact Sciences Corporation | $13.58 | 2023 | Cologuard Collection Kit |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Gary Greenlee listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.